PennyStockSites.com

Rexahn Pharmaceuticals, Inc., AEGEA Inc., Alcatel Lucent Soci and Amarin Corporation Plc from Pennystocksites.com on April 8th, 2014

 

Miami, FL -- (ReleaseWire) -- 04/08/2014 -- Pennystocksites.com a leading online financial newsletter source, Reports on the following Companies: Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), AEGEA Inc. (OTCBB:AEGA), Alcatel Lucent Soci (NYSE:ALU) and Amarin Corporation plc (NASDAQ:AMRN).

Every day we scan the markets for the hottest stocks with the best potential for huge gains. Our vast network is second to none when it comes to delivering fast moving stocks and more importantly getting you out in front of them.

Join Us Here: http://pennystocksites.com/signups/

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for cancer, central nervous system disorders, sexual dysfunction, and other medical needs. Its clinical stage oncology candidates comprise Archexin, an inhibitor of the protein kinase Akt-1, which has completed a Phase IIa clinical trial for the treatment of pancreatic cancer, as well as is focusing on initiating Phase IIa clinical trials for chemo-resistant solid tumors and hematological malignancies; RX-3117, which has completed an exploratory Phase I clinical study in humans with therapeutic potential in a range of cancers, including colon, lung, and pancreatic cancer; and RX-5902, a small molecule that inhibits the phosphorylation of p68 RNA helicase and focuses on initiating Phase I clinical trials. The company’s pre-clinical pipeline consist of RX-0201-Nano, a nanoliposomal anticancer Akt inhibitor; RX-0047-Nano, a nanoliposomal anticancer HIF-1 alpha inhibitor; and RX-21101, nano-polymer anticancer. It has various collaborative research and development relationships with universities, research institutions, and other organizations, including Teva Pharmaceutical Industries; Korea Research Institute of Chemical Technology; The University of Maryland Baltimore; Revaax Pharmaceuticals LLC; and Rexgene Biotech Co., Ltd. The company is based in Rockville, Maryland.

Get a Free Technical Analysis on Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN): http://pennystocksites.com/market-scan/?symbol=rnn

AEGEA Inc. (OTCBB:AEGA), AEGEA Inc. focuses on operating a community and destination resort in South Florida. Its resort would offer various entertainment activities, including special seasonal and cultural events, concerts and shows, street music, and sporting events; indoor and outdoor tournament stadium, and training venues; luxury residencies and resort accommodations; and shops, restaurants, and hotels. The company is based in North Palm Beach, Florida.

Get a Free Technical Analysis on AEGEA Inc. (OTCBB:AEGA): http://pennystocksites.com/market-scan/?symbol=aega

Alcatel Lucent Soci (NYSE:ALU), Alcatel Lucent Société Anonyme provides Internet protocol (IP) and cloud networking, and ultra-broadband fixed and wireless access to service providers and their customers, enterprises, and institutions worldwide. It operates through three segments: Core Networking, Access, and Other. The Core Networking segment provides service routers and switches designed to support IP-based applications and services; and terrestrial optical products, which enable carriers to manage voice, data, and video traffic patterns based on various applications or platforms. It also develops, manufactures, installs, and maintains undersea telecommunications cable networks; and provides microwave radio products, as well as offers network build and implementation IP, platforms, and platforms professional services. The Access segment offers wireless products and services that enable mobile network operators to offer mobile data capacity; cable, antenna, tower systems, and their related electronic components; and fixed access products, which allow service providers to offer high speed broadband connectivity over copper and fiber connections. It also provides wireless and fixed network build and implementation, multivendor maintenance, licensing, and managed services. The Other segment offers communications and network solutions for businesses of various sizes to deliver collaborative conversations. This segment also serves communications needs of government agencies through building converged voice and network infrastructure for various governmental authorities. Alcatel Lucent Société Anonyme serves various industries, including power utilities, oil and gas, defense, public safety, state and local government, highways, and railways. The company was formerly known as Alcatel, S.A. and changed its name to Alcatel Lucent Société Anonyme in November 2006. The company was founded in 1898 and is headquartered in Paris, France.

Get a Free Technical Analysis on Alcatel Lucent Soci (NYSE:ALU): http://pennystocksites.com/market-scan/?symbol=alu

Amarin Corporation plc (NASDAQ:AMRN), Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids. The company lead product comprises Vascepa, a prescription-only omega-3 fatty acid comprising icosapent ethyl as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It also engages in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is headquartered in Dublin, Ireland.

Get a Free Technical Analysis on Amarin Corporation plc (NASDAQ:AMRN),: http://pennystocksites.com/market-scan/?symbol=amrn

Disclosure: We are not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit http://pennystocksites.com/disclaimer/ for complete risks and disclosures.

Contact:
news@pennystocksites.com
http://pennystocksites.com/signups/
http://pennystocksites.com/disclaimer/